Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities

Malaria Clinical Trial

— REACT-2  

Official title:

Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05535465
• Other study ID #: IRD-2-002
• Status: Recruiting
• Phase: N/A
• Start date: December 1, 2021
• Est. completion date: September 1, 2024

Study information

• Verified date: September 2022
• Source: Institut de Recherche pour le Developpement
• Contact: Cédric Pennetier, PhD
• Phone: 0022656080455
• Email: cedric.pennetier[@]ird.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In the REACT 2 project, a consortium proposes to study in Burkina Faso and Côte d'Ivoire, the impact of a public health intervention in rural communities in order to improve access to malaria therapeutic and preventive arsenal for vulnerable populations (i.e. children, adolescents and pregnant women). The intervention relies on the implementation of mobile health workers to support community health workers.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 7500
• Est. completion date: September 1, 2024
• Est. primary completion date: February 1, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Months and older

Eligibility

Inclusion Criteria:

• global population

Exclusion Criteria:

• absence of informed consent

Related Conditions & MeSH terms

• Malaria

Intervention

Other:
• Public health intervention
additional trained mobile health workers are hired to support and supervise the activities of community health workers

Locations

Country	Name	City	State
Burkina Faso	IRSS	Bobo-Dioulasso	Houet
Côte D'Ivoire	IPR	Bouaké

Sponsors (4)

Lead Sponsor	Collaborator
Institut de Recherche pour le Developpement	Expertise France, Institut de Recherche en Sciences de la Sante, Burkina Faso, Institut Pierre Richet

Countries where clinical trial is conducted

Burkina Faso,  Côte D'Ivoire, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Difference of malaria incidence between control and intervention arms	Incidence will be calculated as the number of malaria cases detected during the cross-sectionnal surveys relative to the population size	Day 0 (cross-sectional survey)
Secondary	Difference of malaria prevalence between control and intervention arms	Prevalence will be calculated as the proportion of participants with malaria infection (i.e. positive blood smears) detected during the cross-sectionnal surveys	Day 0 (cross-sectional survey)